Ligand validation:2DXX

SAH: S-ADENOSYL-L-HOMOCYSTEINE

SAH is a Ligand Of Interest in 2DXX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2DXX_SAH_A_1300	84%	18%	0.089	0.951	1.77	1.77	3	8	2	0	100%	1
2DEK_SAH_A_1300	96%	41%	0.063	0.97	0.87	1.42	2	1	0	0	100%	1
2EN5_SAH_A_1301	93%	18%	0.078	0.974	1.75	1.8	3	8	2	0	100%	1
2EL1_SAH_A_1301	93%	14%	0.08	0.976	1.95	1.92	4	7	2	0	100%	1
2E4N_SAH_A_1301	92%	18%	0.074	0.964	1.77	1.78	3	8	2	0	100%	1
2E8H_SAH_A_1301	92%	41%	0.074	0.963	0.88	1.42	2	2	3	0	100%	1
2OB2_SAH_A_1801	100%	22%	0.023	0.994	1.25	1.94	3	4	0	0	100%	1
2BB3_SAH_B_203	100%	9%	0.027	0.993	2.32	2.18	9	6	4	0	100%	1
3LGA_SAH_B_301	100%	22%	0.027	0.994	1.32	1.89	2	3	0	0	100%	1
4QPP_SAH_A_1000	100%	37%	0.025	0.995	0.99	1.46	2	4	0	0	100%	1
8QXQ_SAH_A_401	100%	51%	0.028	0.994	0.84	1.04	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.